Performance of multimodal hyperspectroscopy for scanning of cervix in pregnant women: a preliminary study

Purpose: This study aimed to measure the performance of cervical multimodal hyperspectroscopy (MHS) when compared to Pap smear, and HPV testing in low-risk pregnant women followed up in a university clinical setting. Materials and Methods: Each of 91 pregnant women underwent Pap smear, HPV testing, and during the first 20 weeks of pregnancy. In 84 subjects evaluable data were collected and analyzed. Results: Average age of women was 30 ± 5.2 years. The specificity of MHS performed in pregnant women seems to be significantly better (p < 0.01) than the data of non-pregnant women published earlier. The specificity of MHS in pregnant women with normal Pap smear result is estimated to be 92.9%. The procedure was also well-tolerated with a patient satisfaction rate of 92%. Conclusions: Scanning of the cervix by MHS may perform similar to Pap smear + HPV testing and may have a higher specificity in low-risk pregnant women.

Cervical multimodal hyperspectroscopy; Pap smear; HPV testing; Cervical scanning.

[1] Twiggs L.B., Chakhtoura N.A., Ferris L.C., Flowers L.C., Winter M.L., Sternfeld D.R., et al.: “Multimodal hyperspectroscopy as a triage test for cervical neoplasia: Pivotal clinical trial results”. Gynecol. Oncol., 2013, 130, 147.

[2] Alvarez R.D., Wright T.C., Optical Detection Group: “Effective cervical neoplasia detection with a novel optical detection system: a randomized trial”. Gynecol. Oncol., 2007, 104, 281.

[3] Ferris D., Lawhead R., Dickman E., Holtzapple N., Miller J.A., Grogan S., et al.: “Multi- modal hyperspectral imaging for the noninvasive diagnosis of cervical neoplasia”. J. Low. Genit. Tract Dis., 2001, 5, 65.

[4] Agrawal A., Harrell T., Bambot S., Faupel M., Ferris D.: “Multimodal multispectral im- aging of the cervix in vivo for the detection of neoplasia”. In: Bearman G.H., Bornhop D.J., Levenson R.M., (eds). Biomarkers and biological spectral imaging, 4259. Proc. SPIE, 2001, 68.

[5] Mahadevan A., Mitchell M.F., Silva E., Thomsen S., Richards-Kortum R.R.: “Study of the fluorescence properties of normal and neoplastic human cervical tissue”. Lasers Surg. Med., 1993, 13, 647.

[6] Ramanujam N., Mitchell M.F., Mahadevan A., Warren S., Thomsen S., Silva E., et al.: “In vivo diagnosis of cervical intraepithelial neoplasia using 337-nm-excited laser-induced fluorescence”. Proc. Natl. Acad Sci. U S A, 1994, 91, 10193.

[7] Ramanujam N., Mitchell M.F., Mahadevan-Jansen A., Thomsen S.L., Staerkel G., Malpica A., et al.: “Cervical precancer detection using a multivariate statistical algorithm based on laser-induced fluorescence spectra at multiple excitation wavelengths”. J. Photochem. Photobiol., 1996, 64, 720.

[8] Nordstrom R.J., Burke L., Niloff J.M., Myrtle J.F.: “Identification of cervical intraepithelial neoplasia (CIN) using UV-excited fluorescence and diffuse-reflectance tissue spectroscopy”. Lasers Surg. Med., 2001, 29, 118.

[9] DeSantis T., Chakhtoura N., Twiggs L., Ferris D., Lashgari M., Flowers L., et al.: “Spectroscopic imaging as a triage test for cervical disease: a prospective multicen- ter clinical trial”. J. Low. Genit. Tract Dis., 2007, 11, 18.

[10] Werner C.L., Griffith W.F. III, Ashfaq R., Gossett D., Wilkinson E., Raab S., et al.: “Comparison of human papilloma virus testing and spectroscopy combined with cervical cytology for the detection of high-grade cervical neoplasia”. Low. Genit. Tract Dis., 2007, 11, 73.

[11] Fleury A.C., Birsner M.L., Fader A.N.: “Management of the abnormal Papanicolau smear and colposcopy in pregnancy: an evidence based review”. Minerva Ginekol., 2012, 64, 137.

[12] Weismiller D.G.:” Triage of the abnormal Papanicolau smear and colposcopy in pregnancy”. In: Colposcopy Principles and Practice: An integrated textbook and atlas. Apgar, Brotzman, Spitzer (eds). Philadelphia: WB Saunders, 2002, 391.